GLP-1 Weight Management in Pharmacy — A Complete Guide

GLP-1 receptor agonists have transformed weight management. For pharmacy, they represent the fastest-growing revenue opportunity in a generation.

Semaglutide (Wegovy) and tirzepatide (Mounjaro) are the two dominant treatments. Both are injectable, both require clinical assessment before initiation, and both need ongoing monitoring and dose titration — making them ideal for pharmacy-based delivery under PGD.

The patient demand is extraordinary. Obesity affects over 25% of UK adults. NHS waiting lists for weight management services are measured in months. Online clinics have proliferated, but many offer medication without adequate clinical oversight — post it and forget it. Pharmacy fills the gap: accessible, clinical, face-to-face, and ongoing.

Under PGD, the pharmacist conducts an initial assessment (BMI, medical history, contraindications, current medications), initiates treatment at the appropriate starting dose, and schedules follow-up consultations for dose titration and monitoring. The structured protocol ensures patient safety while creating a natural recurring revenue stream.

Revenue modelling is compelling. GLP-1 treatments generate £200–350 per patient per month. A pharmacy managing 15 active weight management patients generates approximately £36,000–63,000 annually from this single service category. Most patients remain on treatment for 6–12 months, with many continuing longer.

The key differentiator for pharmacy versus online clinics is the ongoing monitoring. Dose titration for both semaglutide and tirzepatide follows a structured escalation schedule. Side effects (nausea, constipation, injection site reactions) need management. Blood pressure and other parameters need checking. This is clinical work — and it's work that online clinics do poorly.

Stock management requires attention. GLP-1 medications are expensive (wholesale cost £150–250 per month) and require cold chain storage. Start with a manageable patient cohort and scale as your supply chain stabilises. Consider patient pre-payment to manage cash flow.

Training covers GLP-1 pharmacology, patient assessment, injection technique (you'll be teaching patients to self-inject), dose titration protocols, side effect management, and when to refer. Expect 6–10 hours of accredited learning.

Do not launch your PGD service portfolio without weight management. It is the service patients are actively searching for, and the pharmacy that offers it locally will capture significant market share.